العلاقة بين نسبة الكريات الحمر الشائكة ودرجة قصور الكبد المزمن
Abstract
شملت الدراسة 48 مريضاً مصاباً بداء كبدي مزمن و/أو تشمع, راجعوا مشفى الأسد الجامعي قسم الأمراض الباطنة خلال العام 2003. تم تصنيف المرضى وفق نظام تشيلد - بوف المعدل إلى ثلاث مجموعات. شكل مرضى Child's A المجموعة الأولى حيث بلغ عددهم 8 ونسبتهم 16.6% وبلغ متوسط نسبة الكريات الشائكة عندهم 1.875 ± 0.413%. وشكل مرضى Child's B المجموعة الثانية وبلغ عدهم 18 مريضاً 37.5% وبلغ متوسط نسبة الكريات الشائكة لديهم 3.844 ± 0.095% بينما شكل مرضى Child's C المجموعة الثالثة وبلغ عددهم 22 مريضاً 45.8% ومتوسط نسبة الكريات الشائكة 7.2 ± 0.555%.
لقد ظهر وجود فروق جوهرية كبيرة جداً بين نسبة الكريات الشائكة في المجموعات الثلاث
(F = 0.05 و0.01)، كما لوحظ وجود فوارق جوهرية بين متوسطات نسب الكريات الشائكة (P = 0.01 وP = 0.001) مما يثبت أن الكريات الشائكة ترتفع في الدم المحيطي لدى مرضى الداء الكبدي المزمن و/أو التشمع مع تقدم درجة القصور الكبدي وبالتالي يمكن أن يعتبر علامة تشير لسوء الإنذار. لقد كانت النسبة لدى مرضى التشمع الكحولي ذوي التصنيف Child's C 7.91 ± 0.183% أعلى منها لدى مرضى Child's C العائد للتشمع النخري6.82 ± 0.149% ومرضى Child's C العائد لتشمع خفي المنشأ 6.36 ± 0.094% (الفارق جوهري عند P = 0.01 و0.001) مما يعني أن الكريات الشائكة تكون أكثر ارتفاعاً عند مرضى الداء الكبدي الكحولي مقارنة بأسباب التشمع الأخرى.
The study included 48 patients with chronic liver disease with/or cirrhosis visited or admitted to Al-Assad university hospital - department of internal medicine during 2003. According to the modified child - pugh system, patients were classified into 3 groups. First group was child's A patients, they were 8 patients (16.6%) with annithamic mean of acanthocytic ratio (1.875 ± 0.413%). Child's B patients were the second group, they were 18 patients (37.5%) and annithamic mean of acanthocytic ratio was (3.844 ± 0.095%). The last 22 patients with child's C were the third group (45.8%) with annithamic mean (7.2 ± 0.555%) for acanthocytes. There were significant differences among the groups. (F = 0.05 & 0.01) and between the annithamic means for acanthocytic ratio (P = 0.01 & 0.001). these findings mean that acanthocytes increase in peripheral blood of patients with chronic liver disease with/or cirrhosis with the progress of hepatic failure and may considered as a sign of bad prognosis. The ratio of acanthocytes in child's C patients with alcoholic liver cirrhosis (7.91 ± 0.183%) was greater than child's C patients with post-necrotic cirrhosis (6.82 ± 0.149%) and child's C patients with cryptogenic cirrhosis (6.36 ± 0.094%) and the difference was significant
(P = 0.01 & P = 0.001).
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series
Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in Tishreen University Journal for Research and Scientific Studies - Health Sciences Series . The Readers have the right to send, print and subscribe to the initial version of the article, and the title of Tishreen University Journal for Research and Scientific Studies - Health Sciences Series Publisher
journal uses a CC BY-NC-SA license which mean
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- The licensor cannot revoke these freedoms as long as you follow the license terms.
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.